PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $283,351 | -24.3% | 107,738 | +1.6% | 0.00% | 0.0% |
Q2 2023 | $374,438 | -41.8% | 106,073 | -49.0% | 0.00% | -50.0% |
Q1 2023 | $643,180 | -46.5% | 208,149 | -26.7% | 0.00% | -50.0% |
Q4 2022 | $1,201,109 | +506.6% | 283,950 | +239.6% | 0.00% | +300.0% |
Q3 2022 | $198,000 | -54.9% | 83,607 | -45.8% | 0.00% | 0.0% |
Q2 2022 | $439,000 | -8.4% | 154,204 | -7.4% | 0.00% | 0.0% |
Q1 2022 | $479,000 | +327.7% | 166,451 | +945.5% | 0.00% | – |
Q3 2021 | $112,000 | -78.0% | 15,920 | -71.3% | 0.00% | -100.0% |
Q2 2021 | $510,000 | -82.8% | 55,558 | -76.1% | 0.00% | -90.0% |
Q2 2019 | $2,959,000 | -40.2% | 232,772 | +82.3% | 0.01% | -37.5% |
Q1 2019 | $4,952,000 | +95.6% | 127,657 | +2.6% | 0.02% | +60.0% |
Q4 2018 | $2,532,000 | +1083.2% | 124,412 | +6866.0% | 0.01% | +900.0% |
Q3 2017 | $214,000 | -90.5% | 1,786 | -90.7% | 0.00% | -90.0% |
Q2 2015 | $2,242,000 | -1.1% | 19,201 | +102.2% | 0.01% | 0.0% |
Q3 2014 | $2,266,000 | +263.1% | 9,497 | -32.5% | 0.01% | +150.0% |
Q2 2013 | $624,000 | – | 14,073 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
State of Wyoming | 20,732 | $59,000 | 0.04% |
Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |